With LendingClub Corp (NYSE:LC) preparing to its annual shareholder meeting on June 28, FBR analyst Bob Ramsey weighs in with a few insights. The analyst maintained a …
In a research report released today, FBR analyst Carter Driscoll reiterated an Outperform rating on shares of FuelCell Energy Inc (NASDAQ:FCEL), with a price …
Galena Biopharma Inc FBR analyst Vernon Bernardino weighs in on Galena Biopharma Inc (NASDAQ:GALE), after the biotech company announced that the FDA has given Fast …
Analysts were out pounding the table on tech giant Apple Inc. (NASDAQ:AAPL) and 3D printing firm Stratasys, Ltd.
In a research report issued Friday, FBR analyst Thomas Yip reiterated an Outperform rating on shares of Peregrine Pharmaceuticals (NASDAQ:PPHM), with a $1.00 price target, …
In a research report released Friday, FBR analyst Christopher James reiterated an Outperform rating on shares of CytRx Corporation (NASDAQ:CYTR), with an $8 price …
Halcon Resources Corp Today has been nothing short of a nightmare for shareholders of oil and gas Halcon Resources Corp (NYSE:HK). Shares of …
Analysts weigh in today on U.S.
Healthcare analysts at sell-side firms FBR and Brean Capital were out today with some commentary on small-cap biotech companies Advaxis, Inc. (NASDAQ:ADXS) and Keryx Biopharmaceuticals (NASDAQ:KERX).
Synthetic Biologics Inc Synthetic Biologics Inc (NYSE:SYN) shareholders are celebrating today after the biotech company reported above-consensus first-quarter results, sending shares up 23%. …